Paper| Volume 37, ISSUE 4, P543-554, February 15, 1985

Fibrin degradation products increase lung transvascular fluid filtration after thrombin-induced pulmonary microembolism

      This paper is only available as a PDF. To read, Please Download here.


      The effect of fibrin degradation products (FDP) on pulmonary transvascular fluid and protein exchange was examined in the sheep lung lymph fistula preparation. The pulmonary lymph was used to assess changes in pulmonary lymph flow (Qlym) (a measure of net transvascular fluid filtration rate) and the lymph/plasma protein concentration ratio (L/P) (a measure of protein seiving across the microvascular barrier). Studies were made in 3 groups: Control Thrombin (n=7) received 96.9±9.4 U/kg of α-thrombin, Control-FDP (n=6) received infusion of FDP prepared by plasmin digestion of fibrin, and Thrombin-FDP (n=5) received thrombin (102.0±7.5 U/kg) and then an FDP infusion was begun at 60 min after the thrombin. In the Control-Thrombin animals, Qlym increased withoug a change in the L/P after thrombin, indicating an increase in vascular permeability to proteins. In the Control-FDP group, infusion of FDP had no effect on Qlym and L/P. In the Thrombin-FDP group, thrombin increased Qlym with no change in the L/P and the subsequent infusion of FDP further increased Qlym but slightly decreased the L/P, an effect not seen in the Control-FDP group. The results indicate that FDP infusion alone does not alter pulmonary transvascular fluid and protein exchange. However, in the presence of thrombin-induced pulmonary microembolization FDP infusion enhances the net transvascular fluid filtration rate, probably by increasing the capillary hydrostatic pressure.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Thrombosis Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Saldeen T.
        The microembolism syndrome: A review.
        in: Saldeen T. The Microembolism Syndrome. Almqvist and Wiksel Internations, Stockholm1979: 7-44
        • Johnson A.
        • Tahamont M.V.
        • Malik A.B.
        Effects of pulmonary embolization induced by thrombin and fibrin microaggregates on lung fluid balance.
        J. Appl. Physiol. 1982; 52: 1565-1570
        • Gerdin B.
        • Sandler H.
        • Saldeen T.
        Pulmonary insufficiency in the rat after intravascular coagulation and inhibition of fibrinolysis.
        Eur. Surg. Res. 1982; 14: 252-261
        • Johnson A.
        • Tahamont M.V.
        • Malik A.B.
        Thrombin-induced lung vascular injury: role of fibrinogen and fibrinolysis.
        Am. Rev. Resp. Dis. 1983; 128: 38-44
        • Luterman A.
        • Manwaring D.
        • Curreri P.W.
        The role of fibrinogen degradation products in the pathogenesis of the respiratory distress syndrome.
        Surgery. 1977; 82: 703-709
        • Manwaring D.
        • Curreri P.W.
        The role of platelet aggregation and release in Fragment D induced pulmonary dysfunction.
        Ann. Surg. 1980; 192: 103-107
        • Manwaring D.
        • Thorning D.
        • Curreri P.W.
        Mechanism of acute pulmonary dysfunction induced by fibrinogen degradation products.
        Surgery. 1978; 84: 45-54
        • Parker J.C.
        • Ryan J.
        • Curreri P.W.
        Effects of fibrinogen degradation products (FDP) on pulmonary vascular permeability to macromolecules.
        Physiologist. 1983; 26: 8
        • Minnear F.L.
        • Barie P.S.
        • Malik A.B.
        Lung fluid exchange in the acute sheep preparation.
        J. Appl. Physiol. 1981; 50: 1358-1361
        • Gunther R.
        • Demling R.
        Effect of diaphragmatic lymph contamination on caudal mediastinal node, CMN, lymph flow in unanesthetized sheep.
        Physiologist. 1981; 24: 53
        • Roos P.
        • Weiner-Kronish J.
        • Albertin K.
        • Mathay M.
        • Staub N.C.
        Removal of subdiaphragmatic contamination on caudal mediastinal node (CMN) efferent lymph contamination in anesthetized sheep.
        Physiologist. 1981; 24: 281
        • Taylor A.E.
        • Parker J.C.
        • Granger D.N.
        • Mortillaro N.A.
        Assessment of capillary permeability using lymphatic protein flux: estimation of the osmotic reflection coefficient.
        in: Taylor A.E. The Microcirculation. Academic Press, New York1981: 19-32
        • Bjorkman S.E.
        A new method for enumeration of platelets.
        Acta haemat. 1959; 22: 377
        • Kaplan J.E
        • Blumenstock F.A.
        • Saba T.M.
        A radial immunodiffusion method for measurement of rat fibrinogen degradation products.
        Vox Sang. 1979; 36: 65-71
        • Kazal L.A.
        • Amsed S.
        • Miller O.P.
        • Tocantins L.M.
        The preparation and some properties of fibrinogen precipitated from human plasma by glycine.
        in: Proc. Soc. Exptl. Biol. Med.113. 1963: 989-991
      1. Fenton, J.W. Thrombin specificity. Math Eq 468–495.

        • Sherry S.
        • Troll W.
        The action of thrombin on synthetic substrates.
        J. Biol. Chem. 1953; 208: 95-105
        • Deutsch D.
        • Mertz E.
        Plasminogen purification from human plasma by affinity plasminogen chromatography.
        Science. 1980; 170: 1095-1099
        • Mullertz J.
        The fibrinolytic system.
        Scand. J. Haemt. 1979; 34: 15-34
        • Visscher M.B.
        • Hadd F.J.
        • Stephens G.
        The physiology and pharmacology of lung edema.
        Pharmacol. Rev. 1956; 8: 389-443
        • Stecher V.J.
        • Sorkin E.
        The chemotactic activity of fibrin lysis products.
        Int. Arch. Allergy Appl. Immunol. 1972; 43: 879-886
        • Sueishi K.
        • Nammo S.
        • Tanaka K.
        Permeability enhancing and chemotactac activities of lower molecular weight degradation products of human fibrinogen.
        Thrombos. Haemostas. 1981; 45: 90-94
        • Goldstein I.M.
        • Malmsten C.L.
        • Kendahl H.
        • Kaplan H.B.
        • Radmark O.
        • Samuelsson B.
        • Weissman G.
        Thromboxane generation by human peripheral blood polymorphonuclear leukocytes.
        J. Exp. Med. 1978; 148: 787-791
        • Minnear F.L.
        • Martin D.
        • Taylor A.E.
        • Malik A.B.
        Large increase in pulmonary lymph flow after thrombin-induced intravascular coagulation.
        in: Fed. Proc.42. 1983: 1274
        • Hammerschmidt D.F.
        Leukocytes in lung injury.
        Chest. 1983; 83: 165-175
        • Belew M.
        • Gerdin B.
        • Porath J.
        • Saldeen T.
        Isolation of vasoactive peptides from human fibrin and fibrinogen degraded from plasmin.
        Thromb. Res. 1978; 13: 983-994
        • Anderson G.G.
        • Saldeen K.
        • Saldeen T.
        A fibrin(ogen) derived pentapeptide induces vasodilation, prostacyclin release and an increase in cyclic AMP.
        Thromb. Res. 1983; 13: 983-994